Current/ Expected Orderbook/ Pending Orders?

The company expects to achieve around Rs. 600 crores in sales in the next six months (H2 of the fiscal year). For international business, approximately USD 650K worth of orders have been completed with one customer in H1. An additional USD 350K to USD 400K of orders are expected from this customer in H2. The overall international business is currently small (around USD 1 million) but is expected to grow as registrations and subsidiaries progress. The company is actively pursuing opportunities in markets like Kenya, Mauritius, Sri Lanka, Vietnam, and others for patented products. Export busines

Any current/future new fundraising through debt or equity?

No immediate plans for new promoter shareholding increase or equity fundraising as per management statements. Fundraising via preferential warrants raised Rs. 37.5 crore out of Rs. 150 crore; remaining Rs. 112.5 crore expected within 18 months as per guidelines. No current foreign currency loans or term loans; existing loans are working capital in nature. Management is focusing on reducing debt and improving cash flows; Rs. 150 crore reduction in debt over last 1.5 years. No new CAPEX planned immediately; fund raising tied to future CAPEX is on hold for 3-6 months to stabilize operations. Over

Any current/future capex/capital investment/strategic investment?

Current CAPEX plans are slow due to focus on stabilizing the business amid challenging conditions. The main planned CAPEX is for an addition at the Gajraula plant. The project start has been delayed by 3 to 6 months to avoid impacting the ongoing rabi season. No other CAPEX projects are currently planned. Financing for the CAPEX is already confirmed and available. The company is re-evaluating the timing of the CAPEX and does not expect it to happen in H2 of the current fiscal year. Fundraising done earlier has not yet been fully utilized for the intended CAPEX purpose.

Future growth expectations in sales/revenue/volumes?

The company aims for a turnover of around Rs. 1,500 crore for FY'26, reflecting a conservative growth outlook. Focus on volume growth recovery expected in the Rabi season, driven by improved farmer sentiment and strong demand for wheat and potato crop solutions. International business is emerging as a new pillar, with revenues from the China subsidiary expected to reach $6-8 million by year-end. Patented product sales are expected to increase, contributing to higher gross margins over the next year. The company plans 2 new patented product launches in the next 12 months, supporting future grow

Future growth expectations in earnings/operating earnings/profits/EPS?

The company aims for volume growth recovery in H2 FY26, driven by improved farmer sentiments and stronger demand. Expectation to achieve EBITDA margins around 13%-14% with a turnover of approximately Rs. 1,500 crore for the fiscal year. Reduction in sales returns by over 50% compared to last year and inventory management is expected to support profitability. Strategic focus on patented product portfolio expansion, with new launches planned, particularly 2 new products next financial year, which is expected to improve margins. Operational efficiencies including OPEX reduction by 11%-13% and bet

IN US

Sale is live|00:00:00left today

Best Agrolife LtdQ3 FY25Fertilizers & Agrochemicals

Best Agrolife Ltd Q3 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹15.5P/E: 28.8Market Cap: ₹697 CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Order

N/A

Capex

0 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

→The company aims for a turnover of around Rs. 1,500 crore for FY'26, reflecting a conservative growth outlook.
→Focus on volume growth recovery expected in the Rabi season, driven by improved farmer sentiment and strong demand for wheat and potato crop solutions.
→International business is emerging as a new pillar, with revenues from the China subsidiary expected to reach $6-8 million by year-end.
→Patented product sales are expected to increase, contributing to higher gross margins over the next year.
→The company plans 2 new patented product launches in the next 12 months, supporting future growth.
→Sales return reduction and better inventory/debtor management to improve sustainability and predictability of revenue.
→Export markets like East Africa, Mauritius, Sri Lanka, Vietnam, and others are targeted for revenue expansion.
→EBITA margin target for H2 FY'26 is around 13%-14%, indicating expectations of improved profitability along with revenue growth.

Margin guidance

Category 3

→The company aims for volume growth recovery in H2 FY26, driven by improved farmer sentiments and stronger demand.
→Expectation to achieve EBITDA margins around 13%-14% with a turnover of approximately Rs. 1,500 crore for the fiscal year.
→Reduction in sales returns by over 50% compared to last year and inventory management is expected to support profitability.
→Strategic focus on patented product portfolio expansion, with new launches planned, particularly 2 new products next financial year, which is expected to improve margins.
→Operational efficiencies including OPEX reduction by 11%-13% and better collection management will aid in sustaining and improving profits.
→The company is optimistic about positive PAT in upcoming quarters as benefits of strategic realignment take effect.
→International business, including exports and operations in China, is expected to become a growth pillar contributing to top line and eventual profitability in future years.

3 more insights locked — sign up free to unlock

Fundraise plans

→No immediate plans for new promoter shareholding increase or equity fundraising as per management statements.
→Fundraising via preferential warrants raised Rs. 37.5 crore out of Rs. 150 crore; remaining Rs. 112.5 crore expected within 18 months as per guidelines.
→No current foreign currency loans or term loans; existing loans are working capital in nature.
→Management is focusing on reducing debt and improving cash flows; Rs. 150 crore reduction in debt over last 1.5 years.
→No new CAPEX planned immediately; fund raising tied to future CAPEX is on hold for 3-6 months to stabilize operations.
→Overall, fundraising efforts are conservatively managed, with no new significant debt or equity issuance planned in near term.

Order book

→The company expects to achieve around Rs. 600 crores in sales in the next six months (H2 of the fiscal year).
→For international business, approximately USD 650K worth of orders have been completed with one customer in H1.
→An additional USD 350K to USD 400K of orders are expected from this customer in H2.
→The overall international business is currently small (around USD 1 million) but is expected to grow as registrations and subsidiaries progress.
→The company is actively pursuing opportunities in markets like Kenya, Mauritius, Sri Lanka, Vietnam, and others for patented products.
→Export business, including Africa, continues with further orders awarded following positive feedback.
→Revenues from the China subsidiary are expected to reach $6 million to $8 million by year-end.
→The company aims for sustainable growth through these pending and expected orders.

Capex plans

→Current CAPEX plans are slow due to focus on stabilizing the business amid challenging conditions.
→The main planned CAPEX is for an addition at the Gajraula plant.
→The project start has been delayed by 3 to 6 months to avoid impacting the ongoing rabi season.
→No other CAPEX projects are currently planned.
→Financing for the CAPEX is already confirmed and available.
→The company is re-evaluating the timing of the CAPEX and does not expect it to happen in H2 of the current fiscal year.
→Fundraising done earlier has not yet been fully utilized for the intended CAPEX purpose.

How does Best Agrolife Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

1Best Agrolife Ltd

Rev 3Mar 3

See full Fertilizers & Agrochemicals sector rankings

Want more stocks like Best Agrolife Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio